Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CTUM receievs approval for tissue bonding from Russia.
http://biz.yahoo.com/bw/070626/20070626006165.html?.v=1
FDA filing is just around the corner. Small float, excellent management, fantastic technology quickly (and finally) moving to the approval/commercial phase.
I think God's watching the Forex at the moment, but if he's tuned in, may God bless Cornell as well for allowing me shares at .04 a pop.
I never thought I'd thank them!
Lowman,
When you're done celebrating the day's news, I have a question.
Do you know what the business arrangement is between CSMG and the Patton (sic) Institue? How will any revenue be divided between the company and the institute?
Also, when the device goes to market, will revenue be accrued on a per-procedure basis or does a surical outfit buy the device and use it as much/little as they desire?
TIA
Agreed 100% with the Bye Byes to Felder and Goulding. The claims made by the company over the past couple of years and the lack of any execution border on the criminal.
I only hope that the company has the goods that it claims to have. Yes, emotions stirred up after management changes do cause former insiders to sell, but even a true stooge holds his shares if he thinks the PPS will rise dramatically from its current state.
Sure would be nice if there was form 4 to review to see if:
1. it's former insiders selling
2. it's new insiders buying
Cutting costs by 50% and increasing R&D 100%....that could be just the savings gained by dumping Feldman's salary, which IMO is the golden nugget in this PR. The other bits about revenue stream and product development.....come on, that's what companies DO. We're so downtrodden here that news of a POTENTIAL revenue stream sounds like the holy grail instead of just another day at the office.
Bret had himself a nasty pile to clean up when he took over. Looks like he's been busy!
No BB listing, no revenue, a litany of un met goals......what would you pay for such a company?
I paid .18, broke my 20% sell rule and will now sit on deck with the other passengers unitl the rescue ship arrives or the Titanic sinks to the bottom of the ocean.
Nobody expected this- even the cheerleaders and ostriches only display their true colors by maintaining the stiff upper lip, stay-the-course reaction as we bleed to new lows.
SO we have 2 options to consider:
1. Bret has nothing to say
2. Bret has nothing he can say
I'm betting on option #1. Ideas and plans are easy to PR and in the past, the company has been outstanding at doing just that. And talk is nowhere cheaper than it is on the Pink Sheets
Partnerships and commercial ventures which lead to revenue are harder to develop and take time. Much longer than expected by all parties. There are a lot of entities out there claiming to have the solution to the energy problem. I'm sure many of them do. I'm equally sure most of them will never become known to the public.
What Bret could do is to clarify which of the past un-met claims are now dead in the water and which of those claims are still viable/being considered actively by the company. Specifically:
1. What's the status of Erie?
2. What's the progress on the move from the pink sheets?
3. What's the status of the previous claims of a big partnership with a household name company to be announced sometime in....well, 2006 or before June 2007....or you name a date.
Yes, I understand negotiations are delicate and need to be kept confidential at times, but I bought into this company on good faith, based on information they provided publically. IMO, Bret has some damage control obligations to those of us who, like him, bought into the hype, but unlike him, have ZERO access to the real picture.
I respect Bret's silence more than the other guy's bogus claims and deadlines. That said, many companies and people have great ideas- making them commercially viable is a whole different game. Bret has his shot now and I'm willing to give him some time to see what he can do.
Yes the FDA process has its bumps and twists. If you know that and I know that, certainly Don and Frank (especially) know it all that much better.
The issue here is with the choice of words for the application date, not with Don's work ethic.
I still hope to see the good news this week.
I gotta' believe DR learned from his "early 2007" blunder when he chose the word "imminent" for his previous PR. While the definition defies an exact time frame, I'm sure we can all agree that "imminent" does not mean the same as "weeks and weeks" or "before the end of next quarter". "Imminent" means this week to me.
Any further delay raises the ugly spectre of the underlying reason for the delay in the FDA filing, as clearly DR thought "early 2007" was a shoo-in. Equally clearly, Frank discovered otherwise. Is the delay due to admin, technology, past results or WTF?
Also delays mean money, which CTUM has very little of. DR's sterling reputation on this board is bolstered by the remarkable lack of dilution. Let's be honest: "early 2007" the DuPont contract, the LTC IPO slated for Nov. 2006....DR has made more than a couple of big-time forecasts that haven't exactly panned out to date.
If a dilution PR comes, overlooking those past promises is gonna be harder to swallow...unless of course there's an FDA filing first.
Lowman,
just curious....do you know how Frank is being paid? shares? Cash? For the LTC application? For the FDA approval?
Also, do you know if Frank's employment status with CSMG is permanent, contractual, on-going, etc.
TIA
A better way to look at the current PPS is to wonder how it jumped to $1.17 so quickly. There was an expectation of a filing that DR repeatedly made. It didn't happen, so here we are.
There's little to support the current PPS in the short term- news of the filing will pop the price but it's a long time between filing, approval and commercialisation.
Even after the news of the FDA application is PR'ed, I anticipate the PPS won't climb parabolically higher until after approval. I'm content to wait the 2-3 years the until the gains are sustained and built upon by revenue, income etc.
Does anyone play or know of an ETF, index fund or optionable mutual fund which follows the holdings of the SSE 100? I'm looking for a way to short the exchange. Thanks
If you do call Don anytime soon, can you ask about the particulars stated in the annual report with regards to additional testing for LTC before they receive FDA approval? It was briefly mentioned in the PR that there was a possibility of the FDA wanting more data, but reading between the lines, it sounds like the FDA will want US of A results from studies done on humans.
Was the company surprised to hear this news?
How will the testing be conducted?
How much will it cost? Where will the money come from?
How long will it take to complete a clinical trial and submit results?
After reading the Q, I'm not thinking that commercialisation will happen in 2007....maybe not in 2008 either.
That may well be the case for the 2006 listing claim. But a claim of up-listing within a time frame of 6 months was made as recently as Dec 06 by the former CEO, who is still an officer and serious insider.
Your inference that the lack of follow-through was the result of a now-gone bad egg is simply not true. In addition to the lack of public financial disclosure, this company has a credibility problem based on unfulfilled claims/intentions. A move to the OTC would go a long way in helping fix that issue.
Bret did say we wouldn't hear anything until there was real news. However, he didn't qualify "news' with the words "good" or "bad". Given the shaky claim-making of previous management, my fear is that Bret found a few warts when he started looking deeper into the books.
If that's the case, will we know about that news as well?
I've begun selling off other positions to acquire as much as possible at these levels. Not since CTUM at .04 a share have I seen an opportunity this ripe. The pedigrees of the new company officers give TDON's claims solid back-up.
In many ways, we're lucky this one's still Pink as it's helping keep the PPS down.
delay in filing. Yawn. Frank knows how to get the FDA nod. When he's sure it's good to go, there'll be news.
started a position in TDON today. A look at the awesome credentials of the new management team that the company has assembled over the past month or so completely eliminates the PK fear-factor. These are serious players with decades of experience and no shortage of work options.
IMO, they chose the company and its technology as much as the company chose them. They must be pretty enthused about the potential to associate with such a small operation.
"Maybe the CFO doesn't want you to know...'
I doubt that most companies publically divulge the names of people buying and selling their shares. Not good practice....unethical, perhaps illegal...
Long term, CTUM has its ducks in a row. Frank is a big-time player who would not have signed on if he didn't see some amazing potential.
The only issue I see with the FDA filing delay is that all time frames get pushed back, ie, FDA acceptance, production, commercialisation, etc, so it'll take a bit longer for my sell price to trigger. But I sleep well at night knowing that when it does trigger, my working days will be over.
TDON beat down to levels not see since the last flurry of PRs and interviews.
I'll be buying from here on down.
Lowman did suggest a PR this week. He didn't hint at its contents. I know we're all hoping that the FDA submission is the news that the PR brings....my only fear is that it isn't....and someone knows it.
I like Don and I'll hold my basket of shares, but it's not the first time a stock has run up on promise only to dwindle down on the lack of delivery. If we don't announce an FDA submission soon, the PPS boost when it does happen might not even bring us to former levels.
Chastang was also put forward as a relatively done deal. It was the excitement surrounding LTC that made us all forget about that one.
Looking for that next corretion in the SSEC. The parabolic rise since the last 10% haircut makes Chinese ETF puts very attractive, especially as FXI offers a 2009 LEAP with reaonable volume. I bought in today, strike price 80.
Even if the China keeps up its unbelievable trajectory, when the US markets cave after whatever the Fed decides to do next, the SSEC will follow.
The tail isn't wagging the dog quite yet.
Logical? I think the term you're looking for is "wishful". lol
Lots and lots of shares sold, with no idea whatsoever if those are insider shares. I guess if I held more than the 37,000 I own I'd be forecasting on emotion as well....it's all we have with NNLX.
Now another dangling Felder carrot- big company, names not mentioned, 6-12 months. Sounds familar.
What I took from the recently posted article is that the results of NNLX's hyro production aren't independently verified. How hard would that be to achieve?
Waiting for some of the great news that was prophesied by the then-CEO in December. I don't know why the appointment of a new CEO, especially a large shareholder and former outsider, would do anything but accelerate the following unless the above bold predictions were pie-in-the-sky pumpage that is the all-too-common domain of pink sheet companies.
-uplisting to the OTC BB
-big news concerning the FDA
-a relationship with "a household name" company
Given that the former CEO is still an intregal part of the company, I would like to know if Mr Barnhizer concurs with those predictions and sees the current lack of activity as merely delays.
Since the time of that interview, the PPS has plunged 45%. In the broader market over that same time frame, you'd be working hard to lose money at such a rate.
Steeledge, I took a look at the website....any idea what the story is with the lawsuit?
DRGG up .02 (28%) on 10X volume.
This is another China play- specialty paper wrapping and associated products. It's lacked any interest over the past 8 months since I bought it, slowly falling form the .11-.12 range to the .07 range. They file, issue PRs and have recently consolidated their biz. No glitz here, but worth a watch, especially with the volume alert.
PBX.V, IPBXF.PK
Nice interview with CEO about current projects at http://smartstox.com/interviews/PBX.php
Some surface level, high grade copper which should generate funds quickly, likely funded by a JV partner. The real story here is the bigger Moly project, with some big potential rhenium mining as gravy. And it's all in Chile.
Management was astute and bought up Chilean properties in the 90's before the current metal rush. Their stakes are 100% owned, the share structure is relatively low even and management has been in the game for a long time.
It's getting harder and harder to find legit Jr's that haven't tripled in the current boom. Volume has been up lately, (including my buy-in of 15,000 shares).
I think Don knows exactly when that filing date will come. If you listen to the interview, he hesitates slighty when he's talking about the FDA submission date, continuing to say, "in the very near future."
Here's hoping that with his understated style, we can expect a big PR within 2 weeks.
TDON
I usually shy away from Pinks but this company has peaked my interest. Any holders here at .75?
Meantime, feel free to help yourself to 25,000 more shares at .07.....couldn't give 'em away this week!
Why sell now? With every PK outfit, all you have is management's performance to guide your investment choices. There's been a lot of money made (and lost) in small caps in the past 18 months. While I don't doubt Dexter's integrity, he ain't gettin' it done in a timely fashion IMO.
Look at Crede's language! "I really think he may be able to pull at least one rabbit out of the hat." Metaphors aside, that isn't how confident investors speak about emerging companies, but at this point, isn't a bit of magic what we're all hoping for?
At the end of the day there's only one question: Is this company a buy right now at this price? It's not for me. If it is for you, I can help you out with a few more shares. LOL
GLTY
The Cornell factor indeed! Many a decent start up has seen its PPS drop remarkably in spite of a seemingly bright future due to a deal with Cornell. But hey, what better time is there to short a company then when you already own the shares to cover?
CTUM saw it's price dip under .04 after Cornell financing. Today it closed over a buck. I'll be watching TXPO for the bottom, but at this point, the knife's still falling.
Yup. The worst case scenario: no contract, no gas production, the company footing the bill for the whole debacle. No new word of another landfill. No indication of why the whole proposal went pear-shaped.
I had high hopes for this end of the biz- the time is certainly ripe for clean energy/carbon credits and all the outstanding PR that would have come from a producing landfill at Chastang.
2 fat but non-producing eggs in a basket is a helluva lot more attractive than one.
My 25,000 shares will be available early next week if that helps. LOL. After holding more than a year, there's too many better places for my investment buck.
GLTA
I've been watching but not tallying......seems over a million shares at least. Here's hoping it's a "big seller" as advertised and not a seller from within.
How many shares did Nutmeg have?
Lack of PPS movement upwards today just confirms the lack of teeth in the latest PR. Companies that make substantial $$$ from licensing deals don't hesitate to let the investment community know all about it. This PR follows on the Hydro-conversion sales-revenue PR, which also didn't do much for the share price.
I hope the CEO fulfills our collective desire for transparency by divulging actual dollar amounts with future PRs of this nature. Pink sheet companies that make vague claims of revenue sharing are opaque at best.
Too many toothless PRs actually erode whatever credibility management may have.
Just wondering what your idea of "sufficient time" is.
IMO, go easy on the Monday expectations for big buying due to the weekend conference. LTC has been presented before with plenty of evidence to support its worth. On those occasions there was no significant change in the volume or the buy interest.
I'm still waiting for DR to backdoor a PR about the now forgotten other end of the CTUM biz- a landfill gas deal or some O&G related activity. Dupont's waiting....
Anyone who is not suspicious of a Pink sheet company is a fool. And anyone who has followed the NNLX story long enough knows that the company has voiced intentions that have not come to fruition. The most offensive of these is the move off the Pinks.
DD is a personal quest: in the case of NNLX, DD is elusive at best because the investor has to rely completely on the word of management alone. (see above).
Message boards really serve one purpose: to make people feel good about their decision to invest money in a company. The board's main purpose is as cyber cheerleader, hence it typically lashes out at any opinion which doesn't agree.
The recent skepticism is hardly surprising given the Pink sheet status and the lack of concrete 411. Nor is the backlash given the nature of message board posters
Congrats EiK.......now, when can we expect the move off the pinks? LOL